AGIOS PHARMACEUTICALS INC 4
4 · AGIOS PHARMACEUTICALS INC · Filed Dec 17, 2015
Insider Transaction Report
Form 4
Higgons John Duncan
Chief Operating Officer10% Owner
Transactions
- Sale
Common stock
2015-12-15$50.09/sh−20,000$1,001,800→ 61,835 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.00 to $50.36. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.